Terms ending in 2042
Janssen Research & Development, LLC
Every in-force patent on Janssen Research & Development, LLC's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,275,766 | Neoantigen Peptide Mimics In force · High confidence | Janssen Biotech, Inc. | In force | High confidence | |
| US 12,030,937 | Anti-Idiotypic Antibodies Against ANTI-GPRC5D Antibodies In force · High confidence | Janssen Biotech, Inc. | In force | High confidence | |
| US 11,639,396 | Antibody Binding to a Linker Peptide In force · High confidence | Janssen Biotech, Inc. | In force | High confidence | |
| US 12,637,509 | Trispecific Antibody Targeting Bcma, GPRC5D, and CD3 In force · High confidence | Janssen Biotech, Inc. | In force | High confidence | |
| US 12,390,451 | Small Molecule Inhibitor of the Jak Family of Kinases In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 12,655,206 | Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody In force · Medium confidence | Janssen Biotech, Inc. | In force | Medium confidence | |
| US 11,814,364 | Pyridine N-Oxide Derivatives Useful as Factor Xia Inhibitors In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 11,845,748 | Bicyclic Pyridine N-Oxide Derivatives Useful as a Factor Xia Inhibitors In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 11,919,881 | Substituted Pyridine N-Oxide Derivatives Useful as a Factor Xia Inhibitors In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 12,775,014 | Multiparameter Materials, Methods and Systems for Enhanced Bioreactor Manufacture In force · Medium confidence | Janssen Biotech, Inc. | In force | Medium confidence | |
| 36 more term ends in 2042 · Pro | |||||
10 of 46 patents shown. Soonest term end first, then patent number.
Pro members see all 46.
2 of these are in force and held by Janssen Research & Development, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.